Treatment with α-cyano-4-hydroxy cinnamate (CHC), a known inhibitor of MCT1, MCT2 and MCT4, dose-dependently induced cell death in MM cell lines and primary MM cells (Figure 1C). This evidence concerns the gene SLC16A7 and Miyoshi myopathy.